Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasiglifam (TAK-875) vs Placebo and Sitagliptin in T2DM on Metformin
NCT01549964Phase 3Terminated
- Sponsor
- Takeda
- Start
- Apr 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Apr 2012; status: terminated.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01549964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549964.